These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9059909)

  • 1. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Sep; 46(9):794-800. PubMed ID: 8254899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
    Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
    Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
    Inoue M; Nonoyama M; Okamoto R; Ida T
    Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
    Suzuki T; Fujita K; Nagamachi Y; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000).
    Tsuchizaki N; Ishino K; Saito F; Ishikawa J; Nakajima M; Hotta K
    J Antibiot (Tokyo); 2006 Apr; 59(4):229-33. PubMed ID: 16830890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
    Tabata M; Shimizu M; Araake M; Ogawa H
    Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
    Yamazaki T; Endo K; Tominaga K; Fukuda M; Maesaki S; Hashikita G; Itabashi A
    Kansenshogaku Zasshi; 2004 Apr; 78(4):305-11. PubMed ID: 15176234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1312-8. PubMed ID: 1479683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Aug; 45(8):958-64. PubMed ID: 1433902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
    Ishii T; Takayama Y; Takase Y; Orikasa Y
    Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.
    Aoki Y
    Jpn J Antibiot; 1994 Jun; 47(6):640-6. PubMed ID: 8072172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
    Kondo S
    Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
    Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
    Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
    Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
    Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.